TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NVCR

Novocure Ltd

Healthcare · Medical Devices

16.70$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Novocure Ltd (NVCR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.8% of the shares are freely tradable; institutional investors hold 88.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 88.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 10.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 82.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 116Mio.

Largest Shareholders

Institutions

Institutions NVCR
Name Stake (%) Shares Change (%) Date
FMR Inc 14.66 17,069,149 +1.6 03/31/2026
BlackRock Inc 11.33 13,193,765 -2.6 03/31/2026
Soleus Capital Management, L.P. 8.51 9,913,401 -5.5 06/30/2026
Vanguard Portfolio Management, LLC 5.37 6,251,701 +0.0 03/31/2026
Vanguard Capital Management, LLC 4.02 4,682,064 +0.0 03/31/2026
Morgan Stanley - Brokerage Accounts 3.90 4,541,526 -10.4 03/31/2026
Wells Fargo & Co 2.53 2,951,237 +1,995.9 03/31/2026

Funds

Funds NVCR
Name Stake (%) Shares Change (%) Date
Fidelity Growth Compy Commingled Pl S 7.04 8,193,334 +0.0 07/31/2026
Fidelity Growth Company Fund 5.04 5,874,496 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.01 3,503,666 +0.4 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?